Drug Development

Listings
  • Anti-CD22 CAR-T Preclinical in vivo Assay

    Anti-CD22 CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Preclinical in vivo assessments of CAR-T are essential for its construct optimization, risk managements, and dosage determination. With years of experience in developing CAR-T therapy solutions, Creative Biolabs offers a broad range of services to su...

  • Anti-CD20 CAR-T Preclinical in vivo Assay

    Anti-CD20 CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Many factors, such as the composition of CAR, the transduction technology, the separation and expansion method of T cells may impact the results of anti-CD20 CAR-T cell therapy. Therefore, preclinical in vivo tests, determining the efficacy, toxicity...

  • Anti-CD19 CAR-T Preclinical in vivo Assay

    Anti-CD19 CAR-T Preclinical in vivo Assay

    Drug Development November 24, 2016 Check with publisher

    Preclinical assessments of CAR-T safety are necessary for its risk managements. Besides, the efficacy and pharmacokinetic characteristics of CAR-T cells should be tested in animal models for CAR optimization and dosage determination. As a frontier bi...

  • Anti-EGFR CAR-T Preclinical in vivo Assay

    Anti-EGFR CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Creative Biolabs has established many in vivo tumor models for testing anti-EGFR CAR-T cells. All animals are maintained in a clean and feed enriched environment before experiments. Animal experiments are monitored under an approved Institutional Ani...

  • Anti-CEA CAR-T Preclinical in vivo Assay

    Anti-CEA CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Creative Biolabs has established various in vivo tumor models and our technical team has extensive knowledge and experience to conduct CAR-T cell evaluation. All animal experiments are monitored under an approved Institutional Animal Care and Use Com...

  • Anti-IL13Rα2 CAR-T Preclinical in vivo Assay

    Anti-IL13Rα2 CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Creative Biolabs provides well-established in vivo tumor models for evaluation of anti-IL13Rα2 CAR-T cells. All animals are maintained in a clean and feed enriched environment before experiments. Our experienced scientist group has extensive knowledg...

  • Anti-EphA2 CAR-T Preclinical in vivo Assay

    Anti-EphA2 CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Creative Biolabs provides well established in vivo tumor models for anti-EphA2 CAR-T cell therapy research. All animals are maintained in a clean and feed enriched environment before experiments. Our experienced group has extensive knowledge and expe...

  • Anti-EGFRvIII CAR-T Preclinical in vivo Assay

    Anti-EGFRvIII CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Therapeutic potential of EGFRvIII in brain and other tumors has been supported by many studies. Recent Phase I clinical trials are already being performed to determine the safety and efficacy of CART-EGFRvIII in the treatment of patients with EGFRvII...

  • Anti-NY-ESO-1 CAR-T Preclinical in vivo Assay

    Anti-NY-ESO-1 CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Our technical team has extensive knowledge and experience for in vivo model development. All animal experiments are monitored under an approved Institutional Animal Care and Use Committee (IACUC) protocol. Creative Biolabs provides various xenograft ...

  • Anti-HER2 CAR-T Preclinical in vivo Assay

    Anti-HER2 CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Creative Biolabs provides various xenograft tumor models to support anti-HER2 CAR-T therapy research. Our technical team has extensive knowledge and experience for in vivo model development. All animal experiments are monitored under an approved Inst...

  • Anti-GPC3 CAR-T Preclinical in vivo Assay

    Anti-GPC3 CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Creative Biolabs established several xenograft tumor models for studies of anti-GPC3 CAR-T therapy. Immunocompromised mice used for tumor model development are housed in pathogen-free condition and quarantined for one week before experiment. Animal e...

  • Anti-GD2 CAR-T Preclinical in vivo Assay

    Anti-GD2 CAR-T Preclinical in vivo Assay

    Drug Development (United States ) November 24, 2016 Check with publisher

    Creative Biolabs fully understand researches of adoptive T cell therapy targeting GD2 are time-consuming and costly. With our highly experienced technical groups and state-of-the-art facilities, Creative Biolabs can accelerate this process by providi...